Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
08:26:46 EDT Sun 16 Jun 2024
Enter Symbol
or Name
USA
CA



A-Labs Capital IV Corp
Symbol ALCC
Shares Issued 4,000,000
Recent Sedar Documents

A-Labs Capital cancels proposed QT with Nanomedic

2023-09-26 15:23 ET - News Release

Subject: press release Word Document File: '\\swfile\EmailIn\20230926 121017 Attachment A-Labs - Press Release - Termination of LOI Nanomedic- October 2023(50147795.1).docx' NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES NEWS RELEASE A-LABS CAPITAL IV CORP. ANNOUNCES TERMINATION OF LETTER OF INTENT AND PROVIDES TRADING UPDATE Vancouver, British Columba -September 27, 2023 - A-Labs Capital IV Corp. (the "Corporation" or 'A-Labs") (TSXV- ALCC.P), a capital pool company listed on the TSX Venture Exchange Inc. ("TSXV") announces that the proposed transaction with Nanomedic Technologies Ltd. for its Qualifying Transaction, has been terminated. Trading in A-Labs shares on the TSXV has been halted at the request of the Corporation and is expected to resume on the TSXV once the resumption review process has been completed. A-Labs, a capital pool company within the meaning of the policies of the TSXV, does not have any operations and has no assets other than cash. The most recent cash balance as at June 30, 2023 (the most recent reporting period) was $6,600. The Corporation's business is to identify and evaluate businesses and assets with a view to completing a Qualifying Transaction under the policies of the TSXV. The Corporation will continue actively looking for a suitable Qualifying Transaction. Cautionary Note Regarding Forward-looking Statements This news release contains forward-looking statements (including, without limitation, information regarding the A-Labs' Qualifying Transaction) that involve risks and uncertainties that could cause the results of A-Labs to differ materially from management's current expectations. Actual results may differ materially due to a number of factors including, among others: the parties may not enter into any future agreement; and A-Labs may not find a target business for its Qualifying Transaction. The matters discussed in this news release also involve risks and uncertainties described in A-Labs' documents filed from time to time with the Canadian securities regulatory authorities. A-Labs assumes no obligation to update the forward-looking information contained in this new release. For further information, please contact: A-Labs Capital IV Corp. Hillar Lilles, Director Hillar@lilles.ca (403) 608-2896 NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

© 2024 Canjex Publishing Ltd. All rights reserved.